A diagram of three specific antibodies bound to chimeric antigen receptors, targeting cells in a well, overlaid on a multi-well plate.

Preview: GMP-Grade Antibody Reagents for Cell Therapy Manufacturing & QC

ASGCT 2026 | Booth 815

 

Evaluate robust, flexible, CAR-T cell enrichment and detection for your manufacturing and QC workflows. Visit Booth 815 to see how the upcoming CST® recombinant monoclonal antibody conjugates that target peptide-linker sequences in scFv-based CARs can help you seamlessly streamline workflows from preclinical development to clinical manufacturing.

Arriving mid 2026, these trusted GMP-grade reagents for development and early-phase analytical QC can: 

  • Speed up and simplify the detection or enrichment of G4S linker CAR+ cells with a single reagent.

  • Save time by using GMP-grade reagents that meet the quality standards required in clinical manufacturing. 

  • Enable smoother hand-offs between preclinical and clinical work.

  • Provide reagent security and supply continuity with GMP-compliant processes and documentation.

<div style="text-align: center; line-height: 1.5;"><span style="font-size: 16px;">Inquire About GMP-Grade Antibody Reagents</span></div>


If you don't need GMP-grade reagents, browse our suite of other cutting-edge solutions for CAR cell characterization.

See how CST can help you: 

  • Detect CAR and target antigen expression with a wide selection of fluorophore conjugates. 

  • Analyze immune cell activation, proliferation, viability, and signaling assays. 

  • Directly interrogate the tumor microenvironment to measure infiltration of CAR-engineered cells.

 

Stop by our poster to see real-world applications of the latest technologies from CST scientists.

Poster Information:

InTraSeq™ Technology Reveals Novel Transcriptomic and Proteomic Dynamics in Activated CAR-T Cells

  • Session Date: Wednesday | May 13, 2026 | 5:00 PM - 6:30 PM

  • Presentation ID/Abstract Number: 2404